Learning Objectives:

 

1.         Identify the challenges in CAR T cell therapy in lymphoma to treatment efficacy and durability of response.

2.         Explore strategies to improve cellular therapy function and efficacy with pharmacologic inhibition of PI3K.

 

Session date: 
10/21/2024 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Alexandra Rojek, MD